Similar articles for PMID: 11850736

Year	Number of Results
1885	1
1987	1
1990	1
1991	1
1998	2
1999	1
2000	5
2001	13
2002	12
2003	12
2004	10
2005	7
2006	8
2007	10
2008	5
2011	2
2012	1
2014	1
2024	0

1

Apomorphine SL (Uprima): preclinical and clinical experiences learned from the first central nervous system-acting ED drug.

Giuliano F, Allard J. Giuliano F, et al. Int J Impot Res. 2002 Feb;14 Suppl 1:S53-6. doi: 10.1038/sj.ijir.3900806. Int J Impot Res. 2002. PMID: 11850736 Review.

2

Central nervous system agents in the treatment of erectile dysfunction.

Kendirci M, Walls MM, Hellstrom WJ. Kendirci M, et al. Urol Clin North Am. 2005 Nov;32(4):487-501, vii. doi: 10.1016/j.ucl.2005.08.006. Urol Clin North Am. 2005. PMID: 16291040 Review.

3

Centrally acting mechanisms for the treatment of male sexual dysfunction.

Miner MM, Seftel AD. Miner MM, et al. Urol Clin North Am. 2007 Nov;34(4):483-96, v. doi: 10.1016/j.ucl.2007.08.008. Urol Clin North Am. 2007. PMID: 17983889 Review.

4

Central mechanisms regulating penile erection in conscious rats: the dopaminergic systems related to the proerectile effect of apomorphine.

Hsieh GC, Hollingsworth PR, Martino B, Chang R, Terranova MA, O'Neill AB, Lynch JJ, Moreland RB, Donnelly-Roberts DL, Kolasa T, Mikusa JP, McVey JM, Marsh KC, Sullivan JP, Brioni JD. Hsieh GC, et al. J Pharmacol Exp Ther. 2004 Jan;308(1):330-8. doi: 10.1124/jpet.103.057455. Epub 2003 Oct 20. J Pharmacol Exp Ther. 2004. PMID: 14569075

5

[Apomorphine and erectile dysfunction].

Tan DQ, Yao Y, Zhang J. Tan DQ, et al. Zhonghua Nan Ke Xue. 2007 Sep;13(9):818-21. Zhonghua Nan Ke Xue. 2007. PMID: 17929561 Review. Chinese.

6

Tolerability and safety of apomorphine SL (Ixense (TM) ).

Montorsi F. Montorsi F. Int J Impot Res. 2003 Apr;15 Suppl 2:S7-9. doi: 10.1038/sj.ijir.3900991. Int J Impot Res. 2003. PMID: 12825097 Review.

7

Peripheral modulation of dopaminergic receptors affects erectile responses in rats.

El-Din MM, Senbel AM, Daabees TT, Sharabi FM. El-Din MM, et al. Basic Clin Pharmacol Toxicol. 2007 Apr;100(4):225-32. doi: 10.1111/j.1742-7843.2006.00013.x. Basic Clin Pharmacol Toxicol. 2007. PMID: 17371526 Free article.

8

Sublingual apomorphine: new preparation. In erectile disorders: a narrow therapeutic margin.

[No authors listed] [No authors listed] Prescrire Int. 2002 Jun;11(59):76-9. Prescrire Int. 2002. PMID: 12068841

9

Oral treatment of erectile dysfunction with apomorphine SL.

Altwein JE, Keuler FU. Altwein JE, et al. Urol Int. 2001;67(4):257-63. doi: 10.1159/000051001. Urol Int. 2001. PMID: 11741126 Review.

10

Apomorphine-induced brain modulation during sexual stimulation: a new look at central phenomena related to erectile dysfunction.

Montorsi F, Perani D, Anchisi D, Salonia A, Scifo P, Rigiroli P, Zanoni M, Heaton JP, Rigatti P, Fazio F. Montorsi F, et al. Int J Impot Res. 2003 Jun;15(3):203-9. doi: 10.1038/sj.ijir.3900999. Int J Impot Res. 2003. PMID: 12904807 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

89 results

Results by year